2011
DOI: 10.1016/j.medin.2010.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Efecto de la administración de las estatinas en la patología crítica no cardiológica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 85 publications
0
1
0
Order By: Relevance
“…Interestingly, a new hypothesis can be formulated: the need for cardioprotection of critically ill patients, and one possible mechanism would be through the limitation of heart rate using beta-blockers [10,11], or even sinus node If channel inhibitors (ivabradine) [12]. Studies are needed with more sample volume that can demonstrate the existence of CI in patients who have had an RMD, and analyze the relationship between tachycardiomyopathy and the debut of myocardial dysfunction in critically ill patients.…”
mentioning
confidence: 99%
“…Interestingly, a new hypothesis can be formulated: the need for cardioprotection of critically ill patients, and one possible mechanism would be through the limitation of heart rate using beta-blockers [10,11], or even sinus node If channel inhibitors (ivabradine) [12]. Studies are needed with more sample volume that can demonstrate the existence of CI in patients who have had an RMD, and analyze the relationship between tachycardiomyopathy and the debut of myocardial dysfunction in critically ill patients.…”
mentioning
confidence: 99%